HPR97 Strategic Implications for Biopharmaceuticals: Navigating the Medicare Price Negotiation Provisions of the Inflation Reduction Act

Abstract

Authors

S Briggs T Marder S Iyer C Francois

Full Text Cite This Article
Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×